Xia Shan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
- Genetics 12
- Glioma Diagnosis and Treatment 12
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 5
- Co-authors
- Wei Zhu (15 shared papers)Xin Min ZHOU (13 shared papers)Wen‐Fang Cheng (10 shared papers)Tongshan Wang (9 shared papers)Huo Zhang (10 shared papers)Zebo Huang (9 shared papers)Lian‐Wen Qi (7 shared papers)Danxia Zhu (7 shared papers)
- Journals
- Oncotarget (4 papers)Gene (3 papers)Cancer Medicine (3 papers)Clinical Immunology (2 papers)Seizure (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xia Shan
38 papers receiving 1.5k citations
Xia Shan's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 660
- Genetics 280
- Molecular Biology 685
- Immunology 97
- Neurology 35
Countries citing papers authored by Xia Shan
This map shows the geographic impact of Xia Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Shan more than expected).
Fields of papers citing papers by Xia Shan
This network shows the impact of papers produced by Xia Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Shan. The network helps show where Xia Shan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Shan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical practice guidelines for the management of adult diffuse gliomas Hit paper breakdown → | 2020 | 283 |
| 2 | 2016 | 151 | |
| 3 | 2018 | 116 | |
| 4 | 2017 | 113 | |
| 5 | 2016 | 68 | |
| 6 | 2021 | 63 | |
| 7 | 2017 | 59 | |
| 8 | 2009 | 57 | |
| 9 | 2019 | 55 | |
| 10 | 2015 | 52 | |
| 11 | 2018 | 50 | |
| 12 | 2019 | 41 | |
| 13 | 2017 | 39 | |
| 14 | 2019 | 34 | |
| 15 | 2018 | 33 | |
| 16 | 2018 | 33 | |
| 17 | 2015 | 28 | |
| 18 | 2017 | 28 | |
| 19 | 2017 | 25 | |
| 20 | 2018 | 22 |
About Xia Shan
Xia Shan is a scholar working on Genetics, Cancer Research, Molecular Biology, Immunology and Oncology, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (5 papers), Extracellular vesicles in disease (5 papers), Immune cells in cancer (3 papers), Ferroptosis and cancer prognosis (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (660 citations), Genetics (280 citations), Molecular Biology (685 citations), Immunology (97 citations) and Neurology (35 citations). Xia Shan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wei Zhu, Xin Min ZHOU, Wen‐Fang Cheng, Tongshan Wang, Huo Zhang, Zebo Huang, Lian‐Wen Qi, Danxia Zhu, Ping Liu and Wei Wen. Their work appears in journals such as Oncotarget, Gene, Cancer Medicine, Clinical Immunology and Seizure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.